SEARCH

SEARCH BY CITATION

References

  • 1
    Hanna J, Wernig M, Markoulaki S et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007;318:19201923.
  • 2
    Wang Y, Zheng CG, Jiang Y et al. Genetic correction of beta-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Cell Res 2012;22:637648.
  • 3
    Papapetrou EP, Lee G, Malani N et al. Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 2011;29:7378.
  • 4
    Lu M, Kardel MD, O'Connor MD et al. Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells. Exp Hematol 2009;37:924936.
  • 5
    Chang KH, Huang A, Hirata RK et al. Globin phenotype of erythroid cells derived from human induced pluripotent stem cells. Blood 2010;115:25532554.
  • 6
    Neel BG, Hayward WS, Robinson HL et al. Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion. Cell 1981;23:323334.
  • 7
    Biffi A, Bartolomae CC, Cesana D et al. Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 2011;117:53325339.
  • 8
    Cavazzana-Calvo M, Payen E, Negre O et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010;467:318322.
  • 9
    Cartier N, Hacein-Bey-Abina S, Bartholomae CC et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009;326:818823.
  • 10
    Amsellem S, Pflumio F, Bardinet D et al. Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med 2003;9:14231427.
  • 11
    Chadwick K, Wang L, Li L et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003;102:906915.
  • 12
    Park IH, Lerou PH, Zhao R et al. Generation of human-induced pluripotent stem cells. Nat Protocol 2008;3:11801186.
  • 13
    Muller LU, Schlaeger TM, DeVine AL et al. Induced pluripotent stem cells as a tool for gaining new insights into Fanconi anemia. Cell Cycle 2012;11:29852990.
  • 14
    Ronen K, Negre O, Roth S et al. Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat beta-thalassemia. Mol Ther 2011;19:12731286.
  • 15
    Negre O, Fusil F, Colomb C et al. Correction of murine beta-thalassemia after minimal lentiviral gene transfer and homeostatic in vivo erythroid expansion. Blood 2011;117:53215331.
  • 16
    Abel U, Deichmann A, Nowrouzi A et al. Analyzing the number of common integration sites of viral vectors–new methods and computer programs. PloS One 2011;6:e24247.
  • 17
    Clarke BJ, Housman D. Characterization of an erythroid precursor cell of high proliferative capacity in normal human peripheral blood. Proc Natl Acad Sci U S A 1977;74:11051109.
  • 18
    McDermott SP, Eppert K, Lechman ER et al. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood 2010;116:193200.
  • 19
    Higgins ME, Claremont M, Major JE et al. CancerGenes: a gene selection resource for cancer genome projects. Nucleic Acids Res 2007;35:D721726.
  • 20
    Singh AM, Dalton S. The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 2009;5:141149.
  • 21
    Ohtsuka S, Dalton S. Molecular and biological properties of pluripotent embryonic stem cells. Gene Ther 2008;15:7481.
  • 22
    Deichmann A, Hacein-Bey-Abina S, Schmidt M et al. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest 2007;117:22252232.
  • 23
    Kobari L, Yates F, Oudrhiri N et al. Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model. Haematologica 2012;97:17951803.
  • 24
    Campbell AD, Cui S, Shi L et al. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes. Proc Natl Acad Sci U S A 2011;108:1880818813.
  • 25
    Papayannopoulou T, Nakamoto B, Kurachi S et al. Globin synthesis in erythroid bursts that mature sequentially in culture. I. Studies in cultures of adult peripheral blood BFU-Es. Blood 1981;58:969974.
  • 26
    Ledran MH, Krassowska A, Armstrong L et al. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem cell 2008;3:8598.
  • 27
    Tian X, Woll PS, Morris JK et al. Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells 2006;24:13701380.
  • 28
    Ambrosi A, Glad IK, Pellin D et al. Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors. PLoS Comput Biol. 2011;7:e1002292.
  • 29
    Schroder AR, Shinn P, Chen H et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002;110:521529.
  • 30
    Wang GP, Ciuffi A, Leipzig J et al. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Gen Res 2007;17:11861194.
  • 31
    Adair JE, Beard BC, Trobridge G et al. Integration-mediated activation of PRDM16 and HMGA2 in multiple clones without adverse hematopoietic consequences following transplant of autologous MGMTP140K gene-modified CD34+ cells. Blood (ASH Meeting Abstracts). 2011;118:Abstract 2053.
  • 32
    Wang GP, Berry CC, Malani N et al. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial. Blood 2010;115:43564366.
  • 33
    Adair JE, Beard BC, Trobridge GD et al. Extended survival of glioblastoma patients after chemoprotective HSC gene therapy. Sci Trans Med. 2012;4:133ra157.
  • 34
    Boztug K, Schmidt M, Schwarzer A et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. NEJM 2010;363:19181927.